MedPath

Prospective observational study to investigate the relationships between pharmacokinetics and therapeutic efficacy and adverse effect of Janus kinase inhibitor in rheumatoid arthritis.

Not Applicable
Conditions
Rheumatoid arthritis
Registration Number
JPRN-UMIN000048381
Lead Sponsor
Department of Hospital Pharmacy, Hamamatsu University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Those who the doctor in charge deems inappropriate Those who do not agree to participate

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Plasma concentration of Janus kinase inhibitors
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath